Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: Influence of experimental and environmental factors

Epilepsy Research

Volumn 33, Issue 2-3, 1999, Pages 199-215

  Ebert, Ulrich ^a   Rundfeldt, Chris ^a   Lehmann, Holger ^a   Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Atmospheric pressure; Kindling parameters; Limbic seizures; Pharmacoresistance; Seasonal influence

Indexed keywords

PHENYTOIN;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATMOSPHERIC PRESSURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG RESISTANCE; DRUG RESPONSE; ELECTRODE; ENVIRONMENTAL FACTOR; FEMALE; FOCAL EPILEPSY; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEASON;

ANIMALS; ANTICONVULSANTS; ATMOSPHERIC PRESSURE; DIFFERENTIAL THRESHOLD; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; ELECTROPHYSIOLOGY; EPILEPSIES, PARTIAL; FEMALE; KINDLING, NEUROLOGIC; MALE; PHENYTOIN; RATS; RATS, WISTAR; SEASONS;

EID: 0033045047     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00086-2     Document Type: Article

References (46)

1. Albright P.S., Burnham W.M. Development of a new pharmacological seizure model: effects of anticonvulsants on cortical and amygdala-kindled seizures in the rat. Epilepsia. 21:1980;681-689.
2. Baimbridge K.G., Miller J.J. Hippocampal calcium-binding protein during commissural kindling-induced epileptogenesis: progressive decline and effects of anticonvulsants. Brain Res. 324:1984;85-90.
3. Bartsch, H., Bartsch, C., Mecke, D., Lippert, T.H., 1994. Seasonality of pineal melatonin production in the rat: possible synchronization by the geomagnetic field. Chronobiol. Int. 11, 21-26.
4. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
5. Bureau Y.R.J., Persinger M.A. Decreased latency for limbic seizures induced in rats by lithium pilocarpine occurs when daily average geomagnetic activity exceeds 20 nanoTesla. Neurosci. Lett. 192:1995;142-144.
6. Callaghan D.A., Schwark W.S. Pharmacological modification of amygdaloid-kindled seizures. Neuropharmacology. 19:1980;1131-1136.
7. Callahan P.M., Paris J.M., Cunningham K.A., Shinnick-Gallagher P. Decrease of GABA-immunoreactive neurons in the amygdala after electrical kindling in the rat. Brain Res. 555:1991;335-339.
8. Cavazos, J.E., Das, I., Sutula, T.P., 1994. Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures. J. Neurosci. 14, 3106-3121.
9. Coggeshall R.E., Lekan H.A. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J. Comp. Neurol. 364:1996;6-15.
10. Dam, M., 1986. Intractable epilepsy: introduction. In: Schmidt, D., Morselli, P.L. (Eds.), Intractable Epilepsy: Experimental and Clinical Aspects. Raven Press, New York, pp. 1-3.
11. Ebert U., Rundfeldt C., Löscher W. Sex differences in the anticonvulsant efficacy of phenytoin in amygdala-kindled rats. Brain Res. 638:1994;45-52.
12. Ebert U., Cramer S., Löscher W. Phenytoin's effect on the spread of seizure activity in the amygdala kindling model. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;341-347.
13. Ebert, U., Löscher, W., 1999. Characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy: influence of genetic factors. Epilepy Res. 33, 217-226.
14. Ehle A.L. Effects of phenytoin on amygdaloid kindled seizures in the rat. Electroencephalogr. Clin. Neurophysiol. 48:1980;102-105.
15. Farghali-Hassan, Assael, B.M., Bossi, L., Garattini, S., Gerna, M., Gomeni, R., Morselli, P.L., 1976. Carbamazepine pharmacokinetics in young, adult and pregnant rats. Relation to pharmacological effects. Arch. Int. Pharmacodyn. Ther. 220, 125-139.
16. Freeman F.G., Jarvis M.F. The effect of interstimulation interval on the assessment and stability of kindled seizure threshold. Brain Res. Bull. 7:1981;629-633.
17. Frey H.H., Löscher W., Reiche R., Schultz D. Anticonvulsant effect of primidone in the gerbil. Time course and significance of the active metabolites. Pharmacology. 28:1984;329-335.
18. Houghton G.W., Richens A., Leighton M. Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients. Br. J. Clin. Pharmacol. 2:1975;251-256.
19. Le Gal La Salle, G., 1981. Amygdaloid kindling in the rat: regional differences and general properties. In: Wada, J.A. (Ed.), Kindling 2. Raven Press, New York, pp. 31-47.
20. Lehmann, H., Ebert, U., Löscher, W., 1998. Amygdala-kindling induces a lasting reduction of GABA-immunoreactive neurons in a discrete area of the ipsilateral piriform cortex. Synapse (in press).
21. Löscher W., Fiedler M. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VI. Seasonal influences on maximal electroshock and pentylenetetrazol seizure thresholds. Epilepsy Res. 25:1996;3-10.
22. Löscher W., Rundfeldt C. Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and non-resistant rats. J. Pharmacol. Exp. Ther. 258:1991;483-489.
23. Löscher W., Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2:1988;145-181.
24. Löscher W., Jäckel R., Czuczwar S.J. Is amygdaloid kindling in rats a model for drug-resistant partial epilepsy? Exp. Neurol. 93:1986;211-226.
25. Löscher W., Hörstermann D., Hönack D., Rundfeldt C., Wahnschaffe U. Transmitter amino acid levels in rat brain regions after amygdala-kindling or chronic electrode implantation without kindling: evidence for a pro-kindling effect of prolonged electrode implantation. Neurochem. Res. 18:1993;775-781.
26. Löscher W., Rundfeldt C., Hönack D. Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Res. 9:1993;11-18.
27. Löscher, W., Ebert, U., Wahnschaffe, U., Rundfeldt, C., 1995a. Susceptibility of different cell layers of the anterior and posterior part of the piriform cortex to electrical stimulation and kindling: comparison with the basolateral amygdala and 'area tempestas'. Neuroscience 66, 265-276.
28. Löscher W., Wahnschaffe U., Hönack D., Rundfeldt C. Does prolonged implantation of depth electrodes predispose the brain to kindling? Brain Res. 697:1995;197-204.
29. Lothman E.W., Williamson J.M., Van Landingham K.E. Intraperitoneal phenytoin suppresses kindled responses: effects on motor and electrographic seizures. Epilepsy Res. 9:1991;11-18.
30. Maggi A., Perez J. Role of female gonadal hormones in the CNS: clinical and experimental aspects. Life Sci. 37:1985;893-906.
31. McNamara J.O. Development of new pharmacological agents for epilepsy: lessons from the kindling model. Epilepsia. 30(Suppl. 1):1989;S13-18.
32. McNamara J.O., Rigsbee L.C., Butler L.S., Shin C. Intravenous phenytoin is an effective anticonvulsant in the kindling model. Ann. Neurol. 26:1989;675-678.
33. Mishra P.K., Dailey J.W., Reigel C.E., Tomsic M.L., Jobe P.C. Sex-specific distinctions in audiogenic convulsions exhibited by severe seizure genetically epilepsy-prone rats (GEPR-9s). Epilepsy Res. 2:1988;309-316.
34. Mohapel P., Dufresne C., Kelly M.E., McIntyre D.C. Differential sensitivity of various temporal lobe structures in the rat to kindling and status epilepticus induction. Epilepsy Res. 23:1996;179-187.
35. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, Sydney.
36. Persinger M.A. Enhancement of limbic seizures by nocturnal application of magnetic fields that simulate the magnitude and morphology of increases in geomagnetic activity. Int. J. Neurosci. 86:1996;271-280.
37. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
38. Rogawski M.A., Porter R.J. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with considerations of promising developmental stage compounds. Pharmacol. Rev. 42:1990;223-286.
39. Rundfeldt C., Löscher W. Anticonvulsant efficacy and adverse effects of phenytoin during chronic treatment in amygdala-kindled rats. J. Pharmacol. Exp. Ther. 266:1993;216-223.
40. Rundfeldt C., Hönack D., Löscher W. Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology. 29:1990;845-851.
41. Schmidt D., Einicke I., Haenel F. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital and carbamazepine. Arch. Neurol. 43:1986;263-265.
42. Vion-Dury J., Rougier I., Le Gal La Salle G., Bras J., Papy J.J. Epileptogenèse par effet d'embrasement en hyperbarie à 3 ATA d'air. J. Physiol. (Paris). 80:1985;32-37.
43. Voits M., Frey H.H. Stimulation-dependent effect of antiepileptic drugs in amygdala kindled rats on both seizure score and duration of afterdischarges. Pharmacol. Toxicol. 75:1994;54-61.
44. Von Mayersbach H. Seasonal influences on biological rhythms of standardized laboratory animals. Chronobiologia. 8:1981;87-91.
45. Walker M.C., Alavijeh M.S., Shorvon S.D., Patsalos P.N. Microdialysis study of the neuropharmacokinetics of phenytoin in rat hippocampus and frontal cortex. Epilepsia. 37:1996;421-427.
46. Wlaz P., Löscher W. The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. V. Lack of seasonal influences on amygdala kindling in rats. Epilepsy Res. 16:1993;131-136.